Stratus Therapeutics is redefining regenerative medicine with Stratus Prime™ — a platform for full hematopoietic system renewal, on demand. Our proprietary product, ST-101, includes both hematopoietic stem cells (Prime HSCs™) and hematopoietic progenitor cells (Prime HPCs™) to drive durable, long-term engraftment with full hematopoietic system restoration, while supporting near-term immune reconstitution.


Biotechnology

Therapeutics

Stratus Therapeutics

Garuda Therapeutics' headquarters in Natick, MA, United States

Adam R. Craig

Alisa Ferguson, MA

David DiGiusto

Tom Crean

David H. Kirske

Albert Paszek

David Scadden

Rahul Singhvi

John E. Wagner

Jerome Ritz

Marcel Van Den Brink

Carl Gordon

Steve Liapis

Ivan Maillard

Katja G. Weinacht

Eric Aguiar

Sean Morrison

Robert Negrin

Raymond J. Kelleher

The Scientist Team at Garuda Therapeutics focuses on the research, development, and quality control of innovative off-the-shelf hematopoietic stem cell (HSC) therapies. They conduct experiments to advance understanding of HSC biology, develop and optimize therapeutic candidates, and ensure the quality and efficacy of produced treatments.

Scientist Team

The Scientific and Technical Team at Garuda Therapeutics focuses on researching, developing, and ensuring the quality of innovative off-the-shelf hematopoietic stem cell (HSC) therapies. They drive scientific discovery, oversee regulatory compliance, manage quality control in CGMP cell therapies, and optimize manufacturing processes to develop treatments for severe and life-threatening diseases.

Scientific and Technical Team

The Director Team at Garuda Therapeutics is responsible for setting strategic direction, overseeing critical projects, and ensuring effective program management across various departments. This team drives the development of off-the-shelf hematopoietic stem cell (HSC) therapies by coordinating talent engagement, resource allocation, and high-level decision-making to advance the company’s mission of treating severe and life-threatening diseases.

Director Team

The Leadership Team at Garuda Therapeutics steers the strategic direction and overall operations of the company. This team ensures the advancement of off-the-shelf hematopoietic stem cell (HSC) therapies, overseeing finance, business development, regulatory compliance, technology, scientific research, manufacturing, and organizational culture—all dedicated to treating severe and life-threatening diseases effectively.

Leadership Team

The Research and Development team at Garuda Therapeutics focuses on advancing off-the-shelf hematopoietic stem cell (HSC) therapies. They conduct preclinical research, develop innovative methodologies, and ensure rigorous analytical assessments to create effective treatments for severe and life-threatening diseases.

Research and Development

The Operations Team at Garuda Therapeutics ensures the seamless functioning of daily activities and strategic initiatives by managing logistics, supply chain, and company resources. They coordinate cross-functional efforts to support the development and delivery of off-the-shelf HSC therapies, handle administrative tasks, and optimize operational processes to meet organizational goals.

Stratus Therapeutics

Org chart

Board & advisors

Teams

Scientist Team

Scientific and Technical Team

Director Team

Leadership Team

Research and Development

Operations Team

Offices

Stratus Therapeutics

Org chart

Board & advisors

Teams

Scientist Team

Scientific and Technical Team

Director Team

Leadership Team

Research and Development

Operations Team

Offices

Related companies